Back
CyberArk Software Vs. Bright Minds Biosciences Industry Stock Comparison
Buy
56
CYBR
CyberArk Software
Last Price:
$319.62
Seasonality Move:
11.42%
Sell
25
DRUG
Bright Minds Biosciences
Last Price:
$37.35
Seasonality Move:
-40.69%
Buy
56
CyberArk Software (CYBR)
is a Buy
Is CyberArk Software a Buy, Sell or Hold?
-
The current CyberArk Software [CYBR] share price is $318.55. The Score for CYBR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
CYBR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $38.69. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYBR Stock Price Chart
What is CyberArk Software's stock price today?
-
The CyberArk Software share price today is $318.55Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYBR is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $38.69The current trend is moderately bearish and DRUG is experiencing slight buying pressure.
CYBR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.64 | Buy |
Relative Strength Index (14 RSI): | 52.91 | Buy |
Chaikin Money Flow: | 241563 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (313.38 - 325.8) | Sell |
Bollinger Bands (100): | (269.01 - 310.99) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 49.39 | Sell |
Chaikin Money Flow: | 2367 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.69 - 42.17) | Sell |
Bollinger Bands (100): | (0.28 - 41.88) | Buy |
CYBR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 316.23 | Buy |
20-day SMA: | 320.16 | Sell |
50-day SMA: | 305.62 | Buy |
200-day SMA: | 271.36 | Buy |
8-day EMA: | 316.98 | Buy |
20-day EMA: | 316.23 | Buy |
50-day EMA: | 306.89 | Buy |
200-day EMA: | 272.29 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.17 | Sell |
20-day SMA: | 39.97 | Sell |
50-day SMA: | 41.03 | Sell |
200-day SMA: | 11.11 | Buy |
8-day EMA: | 38.95 | Sell |
20-day EMA: | 39.32 | Sell |
50-day EMA: | 35.14 | Buy |
200-day EMA: | 16.95 | Buy |
CyberArk Software Earnings Growth & CYBR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.46 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.17 per share, and an increase next year of $0.66 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CyberArk Software Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |